Company: INSP
Filing Date: 2025-03-18
Form Type: DEF 14A
Source: 0001140361-25-009249
Chunk: 47

Company: Inspire Medical Systems, Inc.
Filing Date: 2025-03-18
Form: DEF 14A
Chunk 47
---
 the basis of its consideration of the foregoing and other relevant factors, the Organization and Compensation Committee concluded that Aon was independent and that there were no conflicts of interest. Compensation Peer Group and Peer Selection Process The Organization and Compensation Committee believes that obtaining relevant market and benchmark data is of paramount importance in its executive compensation determinations. Such information provides helpful context and a solid reference point when making compensation decisions, though unique aspects of the Company and our business may ultimately drive compensation decisions that differ from our peers. The Organization and Compensation Committee takes into consideration the structure and components of, and the amounts paid under, the executive compensation programs of other comparable peer companies. This information is derived from public filings and other sources when making decisions about the structure and component mix of our executive compensation program. The Organization and Compensation Committee, with the assistance of Aon, developed a peer group using criteria designed to identify companies that reflect our size (measured by revenue, market capitalization, number of employees, and other size measures) and business profile (generally medical device and health equipment companies). Based on these criteria, the Organization and Compensation Committee approved the following peer group for 2024:

| Atricure, Inc.                       |     | Inari Medical, Inc.                          |     | Natera, Inc.               |
| Axonics Modulation Technologies Inc. |     | Insulet Corporation(1)                       |     | Neogen Corporation(1)      |
| Certara, Inc.(1)                     |     | Integra LifeSciences Holdings Corporation(1) |     | Nevro Corp.                |
| Doximity, Inc.(1)                    |     | iRhythm Technologies, Inc.                   |     | Penumbra, Inc.             |
| Glaukos Corporation                  |     | Lantheus Holdings, Inc.(1)                   |     | Shockwave Medical, Inc.    |
| Globus Medical, Inc.                 |     | Masimo Corporation                           |     | STAAR Surgical Company     |
| Haemonetics Corporation(1)           |     | Merit Medical Systems, Inc.(1)               |     | Tandem Diabetes Care, Inc. |

| (1) | Abiomed, Inc., Cardiovascular Systems, Inc., CareDx, Inc., LeMaitre Vascular, Inc., Mesa Laboratories, and Silk Road Medical were removed from our peer group and Certara, Inc., Doximity, Inc., Haemonetics Corporation, Insulet Corporation, Integra LifeSc